B

Betalin Therapeutics Ltd.

6 employees

Betalin Therapeutics develops a cell therapy solution for insulin-dependent diabetes, an Engineered Micro-Pancreas (EMP).

Basic info

Industry

biotechnology research

Sectors

Type 1 Diabetes
Biotechnology
Health Care
Cell therapy
Wellness
Tissue Engineering and Regenerative Medicine

Date founded

2016

Funding rounds raised

Total raised

$53K

from 1 investors over 1 rounds

B

Betalin Therapeutics Ltd. raised $53K on January 11, 2017

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ